EP1487427A4 - Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline - Google Patents

Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline

Info

Publication number: EP1487427A4
Authority: EP; European Patent Office
Prior art keywords: desmethylselegiline; administering; preventing; methods; peripheral neuropathy
Prior art date: 2002-03-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP03716304A

Other languages

German (de)

French (fr)

Other versions

EP1487427A1 (en

Inventor

Cheryl D Blume

Anthony R Disanto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Somerset Pharmaceuticals Inc

Original Assignee

Somerset Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-04

Filing date

2003-03-04

Publication date

2006-01-18

2003-03-04 Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc

2004-12-22 Publication of EP1487427A1 publication Critical patent/EP1487427A1/en

2006-01-18 Publication of EP1487427A4 publication Critical patent/EP1487427A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP03716304A 2002-03-04 2003-03-04 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline Withdrawn EP1487427A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US36160902P	2002-03-04	2002-03-04
US361609P		2002-03-04
PCT/US2003/006690 WO2003075906A1 (en)	2002-03-04	2003-03-04	Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline

Publications (2)

Publication Number	Publication Date
EP1487427A1 EP1487427A1 (en)	2004-12-22
EP1487427A4 true EP1487427A4 (en)	2006-01-18

Family

ID=27805055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP03716304A Withdrawn EP1487427A4 (en)	2002-03-04	2003-03-04	Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline

Country Status (7)

Country	Link
EP (1)	EP1487427A4 (en)
JP (1)	JP2005525377A (en)
CN (2)	CN100506220C (en)
CA (1)	CA2478026A1 (en)
HK (1)	HK1080716A1 (en)
MX (1)	MXPA04008574A (en)
WO (1)	WO2003075906A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006014973A2 (en) *	2004-07-26	2006-02-09	Teva Pharmaceutical Industries, Ltd.	Pharmaceutical dosage forms including rasagiline
KR101562683B1 (en) *	2007-11-19	2015-10-22	유키지루시 메그밀크 가부시키가이샤	Sense-improving agent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996022068A2 (en) *	1995-01-13	1996-07-25	Somerset Pharmaceuticals, Inc.	Methods and pharmaceutical compositions employing desmethylselegiline
WO1997033572A1 (en) *	1996-03-15	1997-09-18	Somerset Pharmaceuticals, Inc.	Method for preventing and treating peripheral neurophathy by administering selegiline
WO1999018946A1 (en) *	1997-10-14	1999-04-22	Tatton Nadine A	Methods for increasing schwann cell survival

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0241809B1 (en) *	1986-04-16	1990-08-08	ASTA Pharma Aktiengesellschaft	Synergistic association of amantadine and selegiline

2003
- 2003-03-04 JP JP2003574181A patent/JP2005525377A/en active Pending
- 2003-03-04 WO PCT/US2003/006690 patent/WO2003075906A1/en active IP Right Grant
- 2003-03-04 CA CA002478026A patent/CA2478026A1/en not_active Abandoned
- 2003-03-04 CN CNB038085445A patent/CN100506220C/en not_active Expired - Fee Related
- 2003-03-04 CN CNA2006100751330A patent/CN1891213A/en active Pending
- 2003-03-04 EP EP03716304A patent/EP1487427A4/en not_active Withdrawn
- 2003-03-04 MX MXPA04008574A patent/MXPA04008574A/en active IP Right Grant
2006
- 2006-01-13 HK HK06100562.2A patent/HK1080716A1/en not_active IP Right Cessation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996022068A2 (en) *	1995-01-13	1996-07-25	Somerset Pharmaceuticals, Inc.	Methods and pharmaceutical compositions employing desmethylselegiline
WO1997033572A1 (en) *	1996-03-15	1997-09-18	Somerset Pharmaceuticals, Inc.	Method for preventing and treating peripheral neurophathy by administering selegiline
WO1999018946A1 (en) *	1997-10-14	1999-04-22	Tatton Nadine A	Methods for increasing schwann cell survival

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03075906A1 *

Also Published As

Publication number	Publication date
MXPA04008574A (en)	2005-07-13
JP2005525377A (en)	2005-08-25
CA2478026A1 (en)	2003-09-18
CN100506220C (en)	2009-07-01
CN1891213A (en)	2007-01-10
WO2003075906A1 (en)	2003-09-18
AU2003220016A1 (en)	2003-09-22
HK1080716A1 (en)	2006-05-04
CN1646109A (en)	2005-07-27
EP1487427A1 (en)	2004-12-22

Similar Documents

Publication	Publication Date	Title
ZA200503967B (en)	2006-11-29	Agent for preventing or treating neuropathy
IL233205B (en)	2020-04-30	Compounds for treating and preventing pre-eclampsia
EP1535971A4 (en)	2010-01-20	Treated pigment, use thereof, and compound for pigment treatment
EP1484366A4 (en)	2009-09-30	Treated pigment, use thereof, and compound for treating pigment
EP1565644A4 (en)	2006-06-07	Well treating process and system
IL176259A0 (en)	2006-10-05	Compositions and methods for treating diabetes
IL169633A0 (en)	2007-07-04	Combination therapy for treating protein deficiencies
AU2002325435A8 (en)	2005-01-13	Medication and method for treating pathological syndrome
IL164219A0 (en)	2005-12-18	Method for treating and preventing hyparathyroidism
EP1468118A4 (en)	2006-08-02	Methods and compositions for treating cancer
EP1572118A4 (en)	2010-07-14	Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
HUS1300035I1 (en)	2017-10-30	Use of dihydroimidazolones for the treatment of epilepsy in dogs
EP1567198A4 (en)	2006-05-31	Materials and methods for treating ocular-related disorders
GB2425617B (en)	2008-04-16	Device for preventing and treating myopia
AU2003232044A8 (en)	2003-11-17	Composition and method for dermatological treatment
HUP0303243A3 (en)	2012-07-30	Carbamate compounds for use in preventing and treating bipolar disorder
AU2003256526A8 (en)	2004-02-02	Arrangements and methods for treating a subject
GB0201498D0 (en)	2002-03-13	Materials and methods for treating cancer
EP1558238A4 (en)	2006-08-30	Beta-hydroxyphenylaldylamines and their use for treating glaucoma
HUP0401913A3 (en)	2008-02-28	Medicine for preventing and treating bromhidrosis
EP1575993A4 (en)	2007-07-25	Methods for treating patients and identifying therapeutics
AU2003259202A8 (en)	2004-02-09	Compositions and methods for treating and preventing infection
EP1545554A4 (en)	2006-06-14	Methods and compositions for treating diabetes mellitis
IL166062A0 (en)	2006-01-15	Compositions and methods for therapeutic treatment
EP1487427A4 (en)	2006-01-18	Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline

Legal Events

Date	Code	Title	Description
2004-11-05	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2004-12-22	17P	Request for examination filed	Effective date: 20040913
2004-12-22	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
2004-12-22	AX	Request for extension of the european patent	Extension state: AL LT LV MK
2005-03-02	RIN1	Information on inventor provided before grant (corrected)	Inventor name: DISANTO, ANTHONY R.ARD PHARMACEUT. CONSULTING INC Inventor name: BLUME, CHERYL, D.
2006-01-18	A4	Supplementary search report drawn up and despatched	Effective date: 20051202
2006-01-18	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 25/02 20000101ALI20051128BHEP Ipc: A61K 31/137 20000101AFI20051128BHEP
2007-12-26	17Q	First examination report despatched	Effective date: 20071127
2008-09-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2008-10-08	18D	Application deemed to be withdrawn	Effective date: 20080408